Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.

Take two mins to learn more

QV Bioelectronics

QV Bioelectronics

QV Bioelectronics

QV Bioelectronics develops implantable bioelectronic devices that use therapeutic electric fields to treat aggressive cancers such as glioblastoma. Its technology aims to deliver continuous, targeted therapy while reducing systemic side effects compared with conventional treatments.

QV Bioelectronics develops implantable bioelectronic devices that use therapeutic electric fields to treat aggressive cancers such as glioblastoma. Its technology aims to deliver continuous, targeted therapy while reducing systemic side effects compared with conventional treatments.

A photo of the QV Bioelectronics team standing in a line
A photo of the QV Bioelectronics team standing in a line
A photo of a brain scan

Why did we invest in

Why did we invest in

QV Bioelectronics

QV Bioelectronics

?

?

  • Expert-led, well-backed team: Founded by strong clinical and technical people, supported by an experienced medtech board and advisors.

  • Novel glioblastoma technology: GRACE is an implantable device tackling major ‘Quality of Life’ and dosing issues—outshining outdated external EFTs.

  • Large ($4.7B) market, growing fast: Glioblastoma market set to grow 18% by 2028 - GRACE targets a multibillion-dollar opportunity.

  • Defensive IP: Two patents at PCT stage, with strong tech differentiation and expansion plans into other cancers.

  • Clear exit path: Strong M&A/IPO potential with targets like Medtronic or J&J - precedents show high-value, high-multiple deals.

Get in Touch with Our Team.

Get in Touch with Our Team.

Get in Touch with Our Team.

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP; registered in England and Wales (number OC453092).
Authorised and regulated by the Financial Conduct Authority (FRN: 1044826).

Site design by